or Try an Advanced Search...

    Specialty Drugs Stocks List

    Symbol Grade Name % Change
    RAPT F RAPT Therapeutics, Inc. -1.87
    INZY F Inozyme Pharma, Inc. -4.66
    BIIB F Biogen Idec Inc. 1.29
    BCAX F Bicara Therapeutics Inc. -3.32
    FNCH F Finch Therapeutics Group, Inc. -2.40
    ORIC F Oric Pharmaceuticals, Inc. 4.35
    TAK D Takeda Pharmaceutical Company Limited 0.30
    CUE D Cue Biopharma, Inc. -5.50
    OPCH D Option Care Health, Inc. 2.79
    CVS D CVS Caremark Corporation 0.48
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
    Related Stock Lists: Biotechnology Biopharmaceutical Pharmacy Cancer Life Sciences Disease Immunology Medicine Autoimmune Disorders Clinical Medicine Immune Disorders S&P 500 Treatment Of Cancer Tumor Abdominal Pain Alzheimer's Disease Antibodies Antineoplastic Drugs Arcturus Therapeutics Autism Spectrum Disorder

    Related ETFs - A few ETFs which own one or more of the above listed Specialty Drugs stocks.

    Symbol Grade Name Weight
    BIS B ProShares UltraShort Nasdaq Biotechnology 6.12
    IHF D iShares U.S. Health Care Providers ETF 5.29
    PPH D Market Vectors Pharmaceutical ETF 4.6
    MNTL D Tema Neuroscience and Mental Health ETF 4.53
    LBAY D Leatherback Long/Short Alternative Yield ETF 4.36
    View all Specialty Drugs ETFs...
    Compare ETFs
    Compare BIS to IHF Compare BIS to PPH Compare PPH to LBAY

        Specialty Drugs Stocks Recent News

        Date Stock Title
        Nov 21 CVS Optimism over global healthcare sector rises: Jefferies
        Nov 21 CVS Major companies that are also popular short-selling stocks
        Nov 21 TAK Takeda and Alloy Therapeutics partner to make off-the-shelf CAR-T therapies
        Nov 21 CVS Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex'
        Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
        Nov 20 TAK Takeda in deal with Alloy Therapeutics to develop cell therapy platforms for cancer
        Nov 20 CVS Health insurers spike as Trump picks Dr. Oz to head Medicare
        Nov 20 CVS Is CVS Health Stock an Underrated Buy?
        Nov 20 CVS Taiwan Semiconductor and CVS Health have been highlighted as Zacks Bull and Bear of the Day
        Nov 20 CVS Bear of the Day: CVS Health (CVS)
        Nov 20 CVS Oak Street Health co-founder departs CVS
        Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 CVS Cigna, CVS, UnitedHealth PBMs sue FTC over insulin prices case
        Nov 19 CVS CVS Health Options Trading: A Deep Dive into Market Sentiment
        Nov 19 CVS CVS makes deal with Glenview Capital, adds four board seats
        Nov 19 CVS CVS Health Corporation (CVS) Wolfe 2024 Healthcare Conference (Transcript)
        Nov 19 BIIB Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
        Nov 19 CVS CVS Health names Dr. Sreekanth Chaguturu President, Health Care Delivery
        Nov 19 CVS Wells Fargo upgrades CVS Health to Overweight, ups price target to $66
        Nov 19 CVS Company News for Nov 19, 2024
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
        Related Stock Lists: Biotechnology Biopharmaceutical Pharmacy Cancer Life Sciences Disease Immunology Medicine Autoimmune Disorders Clinical Medicine Immune Disorders S&P 500 Treatment Of Cancer Tumor Abdominal Pain Alzheimer's Disease Antibodies Antineoplastic Drugs Arcturus Therapeutics Autism Spectrum Disorder
        Specialty Drugs

        Specialty drugs are medications that are used to treat complex and chronic conditions, such as cancer, multiple sclerosis, and rheumatoid arthritis. They are typically more expensive than traditional medications and require special handling, storage, and administration. Specialty drugs may also require special monitoring and close follow-up with a healthcare provider.

        Browse All Tags